Cradle

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

Patee.io is an AI-powered platform that helps businesses automate their data annotation and labeling tasks. With Patee.io, businesses can easily create, manage, and annotate large datasets, which can then be used to train machine learning models. Patee.io offers a variety of features that make it easy to annotate data, including a user-friendly interface, a variety of annotation tools, and the ability to collaborate with others. Patee.io also offers a number of pre-built models that can be used to automate the annotation process, saving businesses time and money.

CEBRA is a machine-learning method that compresses time series data to reveal hidden structures in the variability of the data. It excels in analyzing behavioral and neural data simultaneously, decoding activity from the visual cortex of the mouse brain to reconstruct viewed videos. CEBRA is a novel encoding method that leverages behavioral and neural data to produce consistent and high-performance latent spaces, allowing for hypothesis testing, label-free usage, and accurate decoding of natural movies from the visual cortex.

Bash Senpai is a terminal assistant powered by ChatGPT that transforms instructions into ready-to-use commands. It provides convenience by allowing users to get answers without leaving the terminal and offers better answers by providing context with questions. The tool also incorporates self-reflection to improve the quality of its responses.

Extractify.co is a website that offers a variety of tools and services for extracting information from different sources. The platform provides users with the ability to extract data from websites, documents, and other sources in a quick and efficient manner. With a user-friendly interface, Extractify.co aims to simplify the process of data extraction for individuals and businesses alike. Whether you need to extract text, images, or other types of data, Extractify.co has the tools to help you get the job done. The platform is designed to be intuitive and easy to use, making it accessible to users of all skill levels.

Quadratic is an infinite spreadsheet with Python, SQL, and AI. It combines the familiarity of a spreadsheet with the power of code, allowing users to analyze data, write code, and create visualizations in a single environment. With built-in Python library support, users can bring open source tools directly to their spreadsheets. Quadratic also features real-time collaboration, allowing multiple users to work on the same spreadsheet simultaneously. Additionally, Quadratic is built for speed and performance, utilizing Web Assembly and WebGL to deliver a smooth and responsive experience.

Sonify is a company that specializes in the intersection of audio, data, and emerging technologies. They design and develop audio-first products and data-driven solutions. Sonify's mission is to make data more accessible and understandable through the use of sound. They believe that sound is a powerful tool that can be used to communicate complex information in a way that is both engaging and informative.

PatentPal is a generative AI tool designed for Intellectual Property, specifically to automate mechanical writing in patent applications. The tool allows users to input their claims by dropping a document into the browser, generate specifications and figures with one click, and export drafts into Word and Visio or PowerPoint. PatentPal generates flowcharts for methods, block diagrams for systems and devices, detailed descriptions of figures, abstracts, and summaries to support all claims. Users can customize generated phrases, create multiple profiles, and switch between them instantly. The tool aims to streamline the patent application process by providing a simple and intuitive platform for users to create high-quality patent applications.

Motif is a technical writing platform that uses artificial intelligence to help you create and maintain technical documentation. It provides a suite of tools and APIs that can be used to automate the documentation process, ensuring that your content is always up-to-date and accurate.

Elicit is a research tool that uses artificial intelligence to help researchers analyze research papers more efficiently. It can summarize papers, extract data, and synthesize findings, saving researchers time and effort. Elicit is used by over 800,000 researchers worldwide and has been featured in publications such as Nature and Science. It is a powerful tool that can help researchers stay up-to-date on the latest research and make new discoveries.

Shaped is a cloud-based platform that provides APIs and tools for building and deploying ranking systems. It offers a variety of features to help developers quickly and easily create and manage ranking models, including a multi-connector SQL interface, a real-time feature store, and a library of pre-built models. Shaped is designed to be scalable, cost-efficient, and easy to use, making it a great option for businesses of all sizes.

Liner is a free and easy-to-use tool that allows users to train machine learning models without writing any code. It provides a user-friendly interface that guides users through the process of importing data, selecting a model, and training the model. Liner also offers a variety of pre-trained models that can be used for common tasks such as image classification, text classification, and object detection. With Liner, users can quickly and easily create and deploy machine learning applications without the need for specialized knowledge or expertise.

Mediar is a generative AI tool that helps users maximize the number of operations they can perform. It is designed to be easy to use and can be used for a variety of tasks, including content creation, data analysis, and software development.

Protocol Pal is a website designed to help users with building protocols. It is a user-friendly platform created by Basam Alasaly, Oceanexplains, and Tkruer. The website aims to simplify the process of creating protocols for various purposes. Users can easily navigate through the platform to generate structured protocols efficiently. Protocol Pal is a valuable tool for researchers, scientists, and professionals who require well-defined protocols for their work.

ABtesting.ai is an AI-powered A/B testing software that helps businesses optimize their landing pages for conversions. It uses GPT-3 to generate automated text suggestions for headlines, copy, and call to actions, saving businesses time and effort. The software also automatically chooses the best combinations of elements to show to users, boosting conversion rates in the process. ABtesting.ai is easy to use and requires no manual work, making it a great option for businesses of all sizes.

Superlinked is a compute framework for your information retrieval and feature engineering systems, focused on turning complex data into vector embeddings. Vectors power most of what you already do online - hailing a cab, finding a funny video, getting a date, scrolling through a feed or paying with a tap. And yet, building production systems powered by vectors is still too hard! Our goal is to help enterprises put vectors at the center of their data & compute infrastructure, to build smarter and more reliable software.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health.

PubCompare is a powerful AI-powered tool that helps scientists search, compare, and evaluate experimental protocols. With over 40 million protocols in its database, PubCompare is the largest repository of trusted experimental protocols. PubCompare's AI-powered search features allow users to find similar protocols, highlight critical steps, and evaluate the reproducibility of protocols based on in-protocol citations. PubCompare is available from any computer and requires no download.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Deep Genomics is a company that uses artificial intelligence (AI) to develop RNA therapies for genetic diseases. The company's AI platform is designed to identify novel targets and evaluate thousands of possibilities to identify the best therapeutic candidates. Deep Genomics is currently developing BigRNA+, which will expand the number of mechanisms and genetic variants the company can pursue.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Bionl is a no-code bioinformatics platform designed to streamline biomedical research for researchers and scientists. It offers a full workspace with features such as bioinformatics pipelines customization, GenAI for data analysis, AI-powered literature search, PDF analysis, and access to public datasets. Bionl aims to automate cloud, file system, data, and workflow management for efficient and precise analyses. The platform caters to Pharma and Biotech companies, academic researchers, and bioinformatics CROs, providing powerful tools for genetic analysis and speeding up research processes.

Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

HoloEye.AI is a transformative AI biological intelligence company that leverages cutting-edge artificial intelligence technology to revolutionize the field of biological research. The platform offers advanced AI solutions for analyzing complex biological data, enabling researchers to gain deeper insights and accelerate scientific discoveries.

Mapmygenome is an AI-powered platform that offers DNA testing products for health, fitness, and beauty. It provides personalized insights based on genetic analysis to help individuals make informed decisions about their health, wellness, and lifestyle choices. With over 23 years of genomics experience and the latest sequencing technology, Mapmygenome aims to empower users to take proactive steps towards improving their overall well-being.

Lavo Life Sciences is an AI-accelerated crystal structure prediction application that aims to accelerate drug development by providing accurate crystal structure predictions for small molecule drugs. The application helps in de-risking pipelines, optimizing solid-state formulations, and avoiding late-stage surprises through cutting-edge AI technology. Lavo Life Sciences combines expertise in AI and computational chemistry to offer fast and efficient solutions for drug development teams, enabling them to discover novel polymorphs and make informed decisions to enhance drug development processes.

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

Allchemy is a resource-aware AI platform for drug discovery. It combines state-of-the-art computational synthesis with AI algorithms to predict molecular properties. Within minutes, Allchemy creates thousands of synthesizable lead candidates meeting user-defined profiles of drug-likeness, affinity towards specific proteins, toxicity, and a range of other physical-chemical measures. Allchemy encompasses the entire resource-to-drug design process and has been used in academic, corporate and classified environments worldwide to: Design synthesizable leads targeting specific proteins Evolve scaffolds similar to desired drugs Design “circular” drug syntheses from renewable materials Interface with and instruct automated synthesis platforms and optimize pilot-scale processes Operate “iterative synthesis” schemes Predict side reactions and create forensic “synthetic signatures” of hazardous/toxic molecules Design synthetic degradation and recovery cycles for various types of feedstocks and functional target molecules

C&EN, a publication of the American Chemical Society, provides the latest news and insights on the chemical industry, including research, technology, business, and policy. It covers a wide range of topics, including analytical chemistry, biological chemistry, business, careers, education, energy, environment, food, materials, people, pharmaceuticals, physical chemistry, policy, research integrity, safety, and synthesis.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Owkin is a full-stack AI biotech company that integrates the best of human and artificial intelligence to deliver better drugs and diagnostics at scale. By understanding complex biology through AI, Owkin identifies new treatments, de-risks and accelerates clinical trials, and builds diagnostic tools to reduce time to impact for patients.

Cerebras is an AI tool that offers products and services related to AI supercomputers, cloud system processors, and applications for various industries. It provides high-performance computing solutions, including large language models, and caters to sectors such as health, energy, government, scientific computing, and financial services. Cerebras specializes in AI model services, offering state-of-the-art models and training services for tasks like multi-lingual chatbots and DNA sequence prediction. The platform also features the Cerebras Model Zoo, an open-source repository of AI models for developers and researchers.

CCDS (Center for Computational & Data Sciences) is a research center at Independent University Bangladesh dedicated to artificial intelligence, data sciences, and computational science. The center has various wings focusing on AI, computational biology, physics, data science, human-computer interaction, and industry partnerships. CCDS explores the use of computation to understand nature and society, uncover hidden stories in data, and tackle complex challenges. The center collaborates with institutions like CERN and the Dunlap Institute for Astronomy and Astrophysics.